Showing 2 posts of 2 posts found.
Clovis Oncology (NASDAQ: CLVS) is set to cut up to 35% of its workforce following the US Food and Drug …
Swiss biotech company Actelion (VTX: ATLN) raised its outlook for 2016 and reported a 12% rise in first quarter net …
NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases
EMA selects TrialAssure anonymisation platform for clinical trial documents
Researchers develop new antifungal compounds with improved safety profile
Lonza and Engitix partner to develop next-generation antibody-drug conjugates
Simris Group appoints Tiffany J Vora as Strategic Advisor